Detalhe da pesquisa
1.
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
Blood
; 142(26): 2327-2331, 2023 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738563
2.
Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure.
Eur J Haematol
; 111(1): 96-102, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971022
3.
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City.
J Oncol Pharm Pract
; 27(2): 389-394, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33459159
4.
Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents.
Ann Pharmacother
; 54(9): 879-898, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079411
5.
Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma.
Blood Adv
; 7(16): 4576-4585, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307169
6.
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.
Leuk Lymphoma
; 63(4): 876-884, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784853
7.
IVAC With or Without Rituximab for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas: Real-World Experience in the Modern Era.
Clin Lymphoma Myeloma Leuk
; 21(12): 873-878, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413005
8.
Corrected calcium versus ionized calcium measurements for identifying hypercalcemia in patients with multiple myeloma.
Cancer Treat Res Commun
; 21: 100159, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31521048
9.
Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations.
Cancers (Basel)
; 10(6)2018 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29882807
10.
Solithromycin: A novel ketolide antibiotic.
Am J Health Syst Pharm
; 74(12): 875-887, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28432048